DD283389A5 - Verfahren zur herstellung neuer hydrierter 1-benzooxacycloalkylpyridincarbonsaeureverbindungen - Google Patents

Verfahren zur herstellung neuer hydrierter 1-benzooxacycloalkylpyridincarbonsaeureverbindungen Download PDF

Info

Publication number
DD283389A5
DD283389A5 DD88323598A DD32359888A DD283389A5 DD 283389 A5 DD283389 A5 DD 283389A5 DD 88323598 A DD88323598 A DD 88323598A DD 32359888 A DD32359888 A DD 32359888A DD 283389 A5 DD283389 A5 DD 283389A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
salt
compound
hydrogen
hydroxy
Prior art date
Application number
DD88323598A
Other languages
German (de)
English (en)
Inventor
Wolfgang Froestl
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD283389A5 publication Critical patent/DD283389A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD88323598A 1987-12-23 1988-12-21 Verfahren zur herstellung neuer hydrierter 1-benzooxacycloalkylpyridincarbonsaeureverbindungen DD283389A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH500887 1987-12-23

Publications (1)

Publication Number Publication Date
DD283389A5 true DD283389A5 (de) 1990-10-10

Family

ID=4286355

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88323598A DD283389A5 (de) 1987-12-23 1988-12-21 Verfahren zur herstellung neuer hydrierter 1-benzooxacycloalkylpyridincarbonsaeureverbindungen

Country Status (11)

Country Link
EP (1) EP0322361A3 (fi)
JP (1) JPH01203379A (fi)
KR (1) KR890009915A (fi)
AU (1) AU2730888A (fi)
DD (1) DD283389A5 (fi)
DK (1) DK718488A (fi)
FI (1) FI885903A (fi)
IL (1) IL88727A0 (fi)
NO (1) NO885711L (fi)
PT (1) PT89291A (fi)
ZA (1) ZA889580B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2642069B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0554247B1 (en) * 1990-05-10 2000-04-26 Pfizer Inc. Neuroprotective indolone and related derivatives
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
US5852040A (en) * 1992-10-30 1998-12-22 Pfizer Inc. Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862239B (en) * 1985-09-03 1986-12-31 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrans and benzothiopyrans
EP0252005B1 (de) * 1986-06-26 1991-07-10 Ciba-Geigy Ag Hydrierte 1-Benzooxacycloalkyl-pyridincarbonsäureverbindungen

Also Published As

Publication number Publication date
IL88727A0 (en) 1989-07-31
EP0322361A2 (de) 1989-06-28
PT89291A (pt) 1989-12-29
ZA889580B (en) 1989-08-30
NO885711L (no) 1989-06-26
NO885711D0 (no) 1988-12-22
DK718488D0 (da) 1988-12-22
AU2730888A (en) 1989-06-29
KR890009915A (ko) 1989-08-04
JPH01203379A (ja) 1989-08-16
EP0322361A3 (de) 1990-01-24
FI885903A (fi) 1989-06-24
DK718488A (da) 1989-06-24

Similar Documents

Publication Publication Date Title
EP1202969B1 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
DE69716062T2 (de) Benzofuran-derivate und deren verwendung
DE2758937A1 (de) Verfahren zur herstellung von, gegebenenfalls an ihrer hydroxygruppe durch eine trialkylsilylgruppe geschuetzten, 4-hydroxypyrrolidin-2-on-1- ylalkylcarbonsaeureestern sowie n-aethyl- 2-(4'-hydroxypyrrolidin-2'-on-1'-yl) -acetamid und dieses enthaltende arzneimittel
DE2110445A1 (de) 1-Benzyl-tetrahydro-2-(1H)pyrimidone
EP0136658A2 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
EP0252005B1 (de) Hydrierte 1-Benzooxacycloalkyl-pyridincarbonsäureverbindungen
DE3149010A1 (de) (+)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3- diazacyclopent-2-en, dessen herstellung und seine verwendung in pharamazeutischen praeparaten
DD283389A5 (de) Verfahren zur herstellung neuer hydrierter 1-benzooxacycloalkylpyridincarbonsaeureverbindungen
EP0192255B1 (de) Bi-2H-pyrroli(di)ndione
DD263289A5 (de) Verfahren zur herstellung disubstituierter piperazine
DE4316117C2 (de) Cycloheptimidazol-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende, therapeutische Mittel
EP0149976A2 (de) Substituierte Imidazole
EP0389425B1 (de) Neue Benzothiopyranylamine
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE69328701T2 (de) Diazabicycloderivate als 5-HT3-Antagonisten
EP0213080B1 (de) Hydropyridin-Derivate
DE2829821C2 (de) R,S-N-[1-phenyl-2-(2-hydroxyäthylamino)-äthyl]- dithiocarbaminsäure, sowie deren Allyl-,Propargyl- und Benzylester und Verfahren zu ihrer Herstellung
EP0229011A1 (de) Trisubstituierte Triazole
EP0248414A2 (de) Aralkylimidazolderivate
DE2653251A1 (de) Azabicyclo eckige klammer auf 3.1.o eckige klammer zu hexan-derivate, ihre herstellung und verwendung
EP0252876A1 (de) Hydrierte 1-Phenoxyalkylpyridin-3-carbonsäureverbindungen
EP0128120A2 (de) Trisubstituierte Oxazolidinone
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
AT375079B (de) Verfahren zur herstellung von neuen trans-2,3,4,4a ,5,9b-hexahydro-1h-pyrido(4,3-b)indolen und ihren pharmazeutisch annehmbaren salzen
EP0239533B1 (de) Pyridin-Derivate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee